Article Text

PDF
Randomised controlled trial
Complete revascularisation in patients with ST-segment elevation myocardial infarction and multivessel disease: contemporary data in context
  1. Amerjeet S Banning1,
  2. Anthony H Gershlick2
  1. 1 Department of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, UK;
  2. 2 University of Leicester, Leicester, UK
  1. Correspondence to : Dr Amerjeet S Banning, Department of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Groby Road, Leicester, LE3 9QP, UK; ab758{at}le.ac.uk

Statistics from Altmetric.com

Commentary on: OpenUrlCrossRefPubMed

Context

Primary percutaneous coronary intervention is recommended in patients presenting with ST-segment Elevation Myocardial infarction (STEMI).1 In 40–60% of STEMI patients there is disease in non-infarct-related arteries (IRAs).2 Such patients have higher mortality rates and incidence of MI.3 Current guidelines suggest PCI should be undertaken to the IRA only.1 However, these were based on numerous, potentially selected-patient retrospective observational studies. The DANAMI-3-PRIMULTI investigators compared complete and culprit-only revascularisation in patients with STEMI and multivessel disease.

Methods

PRIMULTI was a prospective multicentre open-label randomised controlled trial. Patients within 12 h of STEMI were initially …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.